Related Experiment Video
Updated: Oct 25, 2025

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Downregulation of miR-29b is associated with Peyronie's disease
Vinicius Genuino Dos Santos1,2, Gabriel Arantes Dos Santos2, Cristóvão Barbosa Neto3
1São Camilo University Center, Sao Paulo, Brazil.
Background:
Peyronie's disease (PD) is characterized by the formation of fibrous plaque in tunica albuginea, causing several problems in patients. The etiology of this disease is not fully understood, and there are few effective treatments. To better understand the molecular pathways of PD, we studied miR-29b, a microRNA that could be involved with this illness. MicroRNAs are endogenous molecules that act by inhibiting messenger RNA. MiR-29b regulates 11 of 20 collagen genes and the TGF-β1 gene, which are related to PD progression.
Methods:
We compared miR-29b expression in 11 patients with PD and 14 patients without PD (control group). For the patients with PD, we utilized samples from the fibrous plaque (n = 9), from the tunica albuginea (n = 11), and from the corpus cavernosum (n = 8). For the control group, we utilized samples from the tunica albuginea (n = 14) and from the corpus cavernosum (n = 10). MiR-29b expression was determined by q-PCR.
Results:
We found a downregulation of miR-29b in the fibrous plaque, tunica albuginea and corpus cavernosum of patients with PD in comparison with the control group (p = 0.0484, p = 0.0025, and p = 0.0016, respectively).
Conclusion:
Although our study has a small sample, we showed for the first time an evidence that the downregulation of miR-29b is associated with PD.
Insights
Peyronie's disease (PD) involves fibrous plaque formation. This study found lower levels of miR-29b in PD patients, suggesting its role in the disease's molecular pathways.
Area of Science:
- Urology
- Molecular Biology
- Genetics
Background:
- Peyronie's disease (PD) is characterized by tunica albuginea fibrosis, with unclear etiology and limited treatments.
- MicroRNAs, like miR-29b, regulate gene expression and are implicated in fibrotic processes.
- MiR-29b influences collagen genes and TGF-β1, both relevant to PD pathogenesis.
Purpose of the Study:
- To investigate the role of miR-29b in Peyronie's disease.
- To compare miR-29b expression levels in patients with and without PD.
Main Methods:
- Quantitative real-time PCR (q-PCR) was used to measure miR-29b expression.
- Samples were collected from fibrous plaque, tunica albuginea, and corpus cavernosum of PD patients and controls.
Main Results:
- A significant downregulation of miR-29b was observed in the fibrous plaque of PD patients compared to controls (p=0.0484).
- MiR-29b was also downregulated in the tunica albuginea (p=0.0025) and corpus cavernosum (p=0.0016) of PD patients.
- These findings indicate a consistent reduction of miR-29b across affected tissues in PD.
Conclusions:
- This study provides the first evidence linking miR-29b downregulation to Peyronie's disease.
- Reduced miR-29b expression may be a key molecular mechanism contributing to PD development.
- Further research is warranted to explore miR-29b as a potential therapeutic target for PD.
Related Concept Videos
MicroRNAs
MicroRNAs
Neural Regulation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation

